These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III. Shinozaki E; Adachi S; Shoda J; Kawamoto T; Suzuki H; Irimura T; Ohkohchi N Int J Oncol; 2004 Nov; 25(5):1257-65. PubMed ID: 15492813 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of carbohydrate antigen 19-9 in colorectal carcinoma. Shimono R; Mori M; Akazawa K; Adachi Y; Sgimachi K Am J Gastroenterol; 1994 Jan; 89(1):101-5. PubMed ID: 8273774 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of T antigen expression in patients with gastric carcinoma. Chung YS; Yamashita Y; Kato Y; Nakata B; Sawada T; Sowa M Cancer; 1996 May; 77(9):1768-73. PubMed ID: 8646672 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic significance of sialyl Le(x) expression in advanced gastric carcinoma. Futamura N; Nakamura S; Tatematsu M; Yamamura Y; Kannagi R; Hirose H Br J Cancer; 2000 Dec; 83(12):1681-7. PubMed ID: 11104566 [TBL] [Abstract][Full Text] [Related]
6. Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma. Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N Cancer; 1998 Sep; 83(6):1094-101. PubMed ID: 9740073 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of carbohydrate antigen 19-9 in gastric carcinoma. Ikeda Y; Mori M; Kido A; Shimono R; Matsushima T; Sugimachi K; Saku M Am J Gastroenterol; 1991 Sep; 86(9):1163-6. PubMed ID: 1882795 [TBL] [Abstract][Full Text] [Related]